Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Schlessinger

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Dermatologic Clinics|June 17, 2008
Spa dermatology: past, present, and futureJoel Schlessinger
Dermatologic Therapy|December 21, 2007
Skin care for men and its marketingJoel Schlessinger
Journal of Drugs in Dermatology : JDD|June 19, 2020
Efficacy and Safety of Systemic Treatments for Skin and Joint Manifestations in Patients With PsoriasisWilliam Abramovits, Joel Schlessinger
Aesthetic Surgery Journal|July 2, 2011
Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type AJoel Schlessinger, Jeffrey Kenkel, Philip Werschler
The Journal of Clinical and Aesthetic Dermatology|November 25, 2010
Prospective demographic study of cosmetic surgery patientsJoel Schlessinger, Daniel Schlessinger, Bernard Schlessinger
Journal of Drugs in Dermatology : JDD|April 7, 2016
Assessment of a Novel Anti-Aging Hand CreamJoel Schlessinger, Subhash Saxena, Stuart Mohr
Journal of Drugs in Dermatology : JDD|January 18, 2017
Split-Face Comparison of an Advanced Non-Hydroquinone Lightening Solution to 4% HydroquinoneJoel Schlessinger, Subhash Saxena, Stuart Mohr
Journal of Drugs in Dermatology : JDD|June 29, 2019
Safety and Effectiveness of Microfocused Ultrasound for Treating Erythematotelangiectatic RosaceaJoel Schlessinger, Mark Lupin, David McDaniel, et al.
Aesthetic Surgery Journal|April 8, 2017
New Uses of AbobotulinumtoxinA in AestheticsJoel Schlessinger, Erin Gilbert, Joel L Cohen, et al.
Pediatric Dermatology|November 22, 2014
Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 yearsLawrence F Eichenfield, Cecilia Ganslandt, Merle Kurvits, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Dermatologic Clinics|June 17, 2008
Spa dermatology: past, present, and futureJoel Schlessinger
Dermatologic Therapy|December 21, 2007
Skin care for men and its marketingJoel Schlessinger
Journal of Drugs in Dermatology : JDD|June 19, 2020
Efficacy and Safety of Systemic Treatments for Skin and Joint Manifestations in Patients With PsoriasisWilliam Abramovits, Joel Schlessinger
Aesthetic Surgery Journal|July 2, 2011
Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type AJoel Schlessinger, Jeffrey Kenkel, Philip Werschler
The Journal of Clinical and Aesthetic Dermatology|November 25, 2010
Prospective demographic study of cosmetic surgery patientsJoel Schlessinger, Daniel Schlessinger, Bernard Schlessinger
Journal of Drugs in Dermatology : JDD|April 7, 2016
Assessment of a Novel Anti-Aging Hand CreamJoel Schlessinger, Subhash Saxena, Stuart Mohr
Journal of Drugs in Dermatology : JDD|January 18, 2017
Split-Face Comparison of an Advanced Non-Hydroquinone Lightening Solution to 4% HydroquinoneJoel Schlessinger, Subhash Saxena, Stuart Mohr
Journal of Drugs in Dermatology : JDD|June 29, 2019
Safety and Effectiveness of Microfocused Ultrasound for Treating Erythematotelangiectatic RosaceaJoel Schlessinger, Mark Lupin, David McDaniel, et al.
Aesthetic Surgery Journal|April 8, 2017
New Uses of AbobotulinumtoxinA in AestheticsJoel Schlessinger, Erin Gilbert, Joel L Cohen, et al.
Pediatric Dermatology|November 22, 2014
Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 yearsLawrence F Eichenfield, Cecilia Ganslandt, Merle Kurvits, et al.
Pageof 6